INFORMATION ABOUT COMPONENTS OF EQUITY - Shares summary (Details)
|
Mar. 14, 2019
shares
|
Jun. 30, 2020
USD ($)
Vote
$ / shares
shares
|
| INFORMATION ABOUT COMPONENTS OF EQUITY |
|
|
| Par value per share | $ / shares |
|
$ 0.0001
|
| Warrants outstanding |
|
12,700,000
|
| Principal amount of convertible notes | $ |
|
$ 42,500,000
|
| Options incentive Plan |
|
|
| INFORMATION ABOUT COMPONENTS OF EQUITY |
|
|
| Stock options granted under share option agreements | $ |
|
1,200,000
|
| Ordinary shares |
|
|
| INFORMATION ABOUT COMPONENTS OF EQUITY |
|
|
| Number of shares authorised |
|
100,000,000
|
| Par value per share | $ / shares |
|
$ 0.0001
|
| Number of shares issued |
|
36,120,517
|
| Number of shares outstanding |
|
36,120,517
|
| Vote per share | Vote |
|
1
|
| Preference shares |
|
|
| INFORMATION ABOUT COMPONENTS OF EQUITY |
|
|
| Number of shares authorised |
|
1,000,000
|
| Par value per share | $ / shares |
|
$ 0.0001
|
| Number of shares issued |
|
0
|
| Number of shares outstanding |
|
0
|
| Public warrants |
|
|
| INFORMATION ABOUT COMPONENTS OF EQUITY |
|
|
| Number of shares issued |
|
11,500,000
|
| Founder warrants |
|
|
| INFORMATION ABOUT COMPONENTS OF EQUITY |
|
|
| Issue of convertible instruments in shares |
5,200,000
|
|
| Bioceres warrants |
|
|
| INFORMATION ABOUT COMPONENTS OF EQUITY |
|
|
| Issue of convertible instruments in shares |
7,500,000
|
|